Jun. 25 at 8:07 PM
$LIPO POS 😂😂😂:
New statement:
“ Final topline data from the Phase 2a trial of LP-310 is expected in the second half of 2025.”
Statement of 15 May:
“ We look forward to sharing final topline data from the fully enrolled trial in the second quarter of 2025.”
This is how crap they are …😂😂😂